NEW YORK, March 4 -- There aren’t likely to be many ethical or legal hurdles in the development of drugs that slow or reverse the cognitive decline of normal aging, experts say.
NEW YORK, March 4 -- There aren’t likely to be many ethical or legal hurdles in the development of drugs that slow or reverse the cognitive decline of normal aging, experts say.
